As a former U.S. Army Captain, Alex Gorsky knows how to lead a battle. And right now, the Johnson & Johnson Chairman and CEO, alongside employees across the globe, is hard at work innovating solutions in the battle against COVID-19.
Innovations like a potential COVID-19 vaccine, which the company started working on in January. In June, Johnson & Johnson announced it was accelerating the initiation of the Phase 1/2a human clinical trial for its investigational vaccine candidate.
Yesterday, Gorsky appeared as a featured speaker at the annual Fortune Brainstorm Health conference, which focused this year on what we’ve learned from the COVID-19 pandemic, how we can weather the continuing storm—and prepare for the next.
Watch his interview with conference co-chair David Agus, M.D., Founding Director and CEO of the Lawrence J. Ellison Institute for Transformative Medicine at the University of Southern California, in the video below.
Gorsky discussed Johnson & Johnson’s response to the pandemic, the company’s rapid progress toward advancing a vaccine—and how COVID-19 has affected virtually every aspect of health and medical care.
“Hopefully some of the lessons we’re learning now in working with different entities can lead to the kind of collaborations we continue in the future,” Gorsky says. “That could be one of the silver linings in the long term that the industry and healthcare systems take away.”
Video courtesy of FORTUNE
